Practical stress management program found to improve health of people with type 2 diabetes

August 24, 2002

CHICAGO -- Stress management is important for good health for all Americans, but for people with diabetes it is especially beneficial. New research shows a "real world" group stress management program can result in significant benefits for those with type 2 diabetes by improving glucose metabolism, thus reducing blood sugar levels. Results of the study will be presented at the 110th Annual Convention of the American Psychological Association (APA) in Chicago.

The study involved 108 patients, age 30 or older, with type 2 diabetes who went through a five-session group diabetes education program with or without stress management training. The stress management program included education on the health consequences of stress, instruction in the use of cognitive and behavioral skills to recognize and reduce physiological stress levels (such as deep breathing and recognition of major stressors in life) and progressive muscle relaxation (PMR), which included consecutively tensing and relaxing muscle groups in the body.

The participants' stress levels and hemoglobin A1C (HbA1c) levels were measured at regular intervals for a one-year period to evaluate the effects of the treatment. HbA1c is the substance of red blood cells that carries oxygen to the cells and sometimes joins with glucose and what is measured to determine if a person has type 2 diabetes.

By the end of one year, 32 percent of the stress management participants had HbA1c levels that were lower by one percent or more. By contrast, only 12 percent of the control participants (those receiving no stress management training) had levels that were reduced by that much. Although the change was only modest, even changes as small as a half percent have been associated with significant reduction in microvascular complications that can accompany out-of-control diabetes, according to study lead author Richard S. Surwit, Ph.D., of the Duke University Medical Center.

"For someone already in good control of their diabetes, the reduction in HbA1c might bring them to near normal levels. For those in poorer control, it probably would not, but the reduction is associated with fewer diabetes complications for them as well," said Dr. Surwit.

While group stress management training was successful in improving glycemic control in this study, Dr. Surwit cautions that such training may not work as well with all patients, especially those who have adverse metabolic control due to acute stress.

The study, published earlier this year in the journal Diabetes Care, is available from the APA Public Affairs Office.

Presentation: "Stress Management and Treatment of Diabetes," Richard S. Surwit, Ph.D., Duke University Medical Center; Session 3188, 1:00 - 2:50 PM, August 24, 2002, McCormick Place, South Building-Level 4, Meeting Room S405b.
Dr. Richard Surwit can be reached before and after the convention at (919) 684-4317 or by e-mail at

A complete listing of press releases and media advisories for the APA Annual Convention is available at:

The American Psychological Association (APA), in Washington, DC, is the largest scientific and professional organization representing psychology in the United States and is the world's largest association of psychologists. APA's membership includes more than 155,000 researchers, educators, clinicians, consultants and students. Through its divisions in 53 subfields of psychology and affiliations with 60 state, territorial and Canadian provincial associations, APA works to advance psychology as a science, as a profession and as a means of promoting human welfare.

Contact: David Partenheimer
Public Affairs Office
(202) 336-5706 (until 8/21)
(312) 808-2350 (between 8/22-8/25)

American Psychological Association

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to